To combat the spread of the new Omicron COVID variant, the European Union stated that it intends to ban air travel from southern Africa. Scientists in South Africa have discovered a Coronavirus strain that is causing alarm due to its high number of mutations and quick transmission. A fourth Coronavirus outbreak is wreaking havoc with Europe's policymakers scrambling to tighten restrictions in an attempt to curb the spread.
Courtesy: Press Trust Of India
Coronavirus infections have hit new highs in Europe, making the continent the epicenter of the pandemic. According to reports, Europe, Slovakia, Czech Republic, Netherlands, and Hungary reported new highs in daily infections of Covid-19. Moreover, the European Centre for Disease Prevention and Control (ECDC) has advised vaccination boosters for all adults, with a focus on those above 40 years of age. "The situation is serious," said Slovakian… read-more
People in Netherlands, France, and Belgium continued to protest on the COVID-19 curbs. According to reports, people continued to show up in numbers across the European cities with police deploying water cannons and tear gases to disperse the crowd. In view of increasing Corona Virus cases, the European Union had to issue tighter restrictions to curb the virus, where citizens are demanding to remove the mandate of compulsory vaccination.
The Romanian government on October 23, introduced emergency restrictions with night curfews, as well as sending school children on vacation for two weeks due to a rise in COVID-related cases. Moreover, the country recorded a high number of deaths due to Coronavirus stretching the hospital system to a breaking point. As per reports, the country has the second-lowest vaccination rate in the European Union.
After India's formal request & threaten with mandatory quarantine, the seven EU nations have now agreed on June 1 to include Covishield & Covaxin in the Green Pass list. Switzerland, Iceland, and other EU nations - Austria, Germany, Slovenia, Greece, Ireland, Estonia, and Spain have accepted the Indian Serum Institute-manufactured Covishield vaccine for travel. However, Covaxine is yet to be cleared by WHO.
Courtesy: The Times of India
Serum Institute of India's Covishield vaccine is cleared for a travel pass in eight EU nations- Austria, Germany, Slovenia, Greece, Estonia, Iceland, Ireland, Spain, and Switzerland. Amidst issues of Covishield's travel pass clearance, Adar Poonawalla, CEO of Serum Institute tweeted on June 28, "I have taken this up at the highest levels and hope to resolve this matter soon." In the past, EMA had cleared only four vaccines.
The decision to include the Indian-made Covishield vaccine in the COVID-19 vaccination passport is still uncertain from EU's end. Many Covishield-vaccinated Indians are facing issues traveling to Europe as the EU failed to recognize the vaccine. Raising concerns over not including Covishield, the CEO of Serum Institute (Covishield manufacturer) said, "This will affect students, business travelers, and cause severe disruptions to our economy… read-more
According to sources, Alphabet subsidiary Google may face its most serious regulatory challenge yet. The EU's antitrust authorities are planning to launch a formal probe into its profitable digital advertising business, by the end of the year. The investigation would concentrate on Google's position in relation to advertising, publishers, middlemen, and competitors. Last year, Google had earned $147 billion from its online add business.
Courtesy: WION News
Japan has come up with a way to allow Japanese tourists to travel around the world from next month: a vaccine passport. On June 17, Japan's top official announced that local governments will issue a paper-based vaccine certificate for the citizens that wish to travel outside the country. Other governments such as the EU are looking into digital vaccine passports in a desperate attempt to open touristy soon.
Pfizer-BioNTech's COVID-19 vaccine has become the first vaccine globally to be approved for children aged between 12-15 years. The vaccine was approved by the European Union drug regulator on May 28 with no "major concerns" remark. Following the approval, Germany plans to start vaccinating those aged 12 and above in June. Notably, the trials of the vaccine were conducted on 1,005 children and none of them developed any major side-effect.… read-more